GlassScriptPhysician profile
Christopher Enriquez
NPI 1477152163
$1,045.56
in general payments reported to CMS, 2019-2025
9 companies · $68.97 in 2025
The $68.97 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $442 · 2023: $497 · 2024: $37.48 · 2025: $68.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.19 | 2022-2023 | Jardiance |
| Irhythm Technologies, INC. | $194.42 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $147.96 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $140.53 | 2022-2023 | Farxiga |
| Pfizer INC. | $118.14 | 2022 | |
| Novo Nordisk INC | $98.69 | 2023 | Wegovy |
| Sage Therapeutics, LLC | $50.03 | 2025 | Zurzuvae |
| Amgen INC. | $37.66 | 2023 | Repatha |
| Organon LLC | $18.94 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Enriquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.